Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
European Journal of Haematology|February 14, 2022
Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic reviewMartin Vu, Koen Degeling, Ella R Thompson, et al.
Applied Health Economics and Health Policy|August 23, 2023
Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in AustraliaMartin Vu, Koen Degeling, Ella R Thompson, et al.
Pathology|March 9, 2021
CAR-T cell therapy: practical guide to routine laboratory monitoringAdrian G Selim, Adrian Minson, Piers Blombery, et al.
European Journal of Haematology|May 22, 2015
The molecular pathogenesis of B-cell non-Hodgkin lymphomaPiers A Blombery, Meaghan Wall, John F Seymour
Pathology|September 24, 2022
Clinically relevant variation in FLT3-ITD quantitation as a result of PCR cycle number and ITD insertion sizeIng S Tiong, Nikky Andrieska, Phuong Dang, et al.
British Journal of Haematology|February 10, 2025
Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosisRithin Nedumannil, Tal Karmi, Piers Blombery, et al.
Pathology|February 27, 2024
Observations from a national sample exchange program for molecular haematology testingClare Gould, Michelle McBean, Ella Thompson, et al.
The Australasian Journal of Dermatology|May 26, 2026
A Case of Primary Cutaneous BRAFV600E+ Langerhans Cell Histiocytosis, With Underlying Chronic Myelomonocytic Leukaemia, Responsive to Dabrafenib With Subsequent Undetectable Circulating Cell Free DNAKate Simpson, Friyana Bhabha, Alicia Snowden, et al.
British Journal of Haematology|April 13, 2023
Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemiaPhillip C Nguyen, Vuong Nguyen, Kylie Baldwin, et al.
Blood Advances|February 17, 2018
Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapySara Mastaglio, Eric Wong, Travis Perera, et al.
Pageof 16